NYSEARCA:GERM Amplify Treatments, Testing and Advancements ETF (GERM) Price, Holdings, & News $19.16 0.00 (0.00%) As of 08/8/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsBuy This Stock About Amplify Treatments, Testing and Advancements ETF (NYSEARCA:GERM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get GERM alerts:Sign Up Key Stats Today's Range$19.16▼$19.1650-Day Range$19.16▼$19.1652-Week Range$15.67▼$20.20VolumeN/AAverage Volume1,891 shsMarket Capitalization$9.58 millionAssets Under Management$9.67 millionDividend Yield1.20%Net Expense Ratio0.68%Aggregate RatingN/A ETF Overview The ETFMG Treatments, Testing and Advancements ETF (GERM) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a tier-weighted, narrow index of US-listed, global biotech companies that are engaged in the testing and treatments of infectious diseases. GERM was launched on Jun 17, 2020 and is managed by ETF Managers Group. Read More Amplify Treatments, Testing and Advancements ETF ExpensesTypeGERMTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.68%0.57%0.56%0.51%0.53%Other Expenses0.00%0.57%0.56%0.59%0.56%Total Expense0.68%0.74%0.76%0.74%0.73%Fee Waiver0.00%-0.76%-0.66%-0.71%-0.63%Net Expense0.68%0.60%0.63%0.58%0.60% Receive GERM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Amplify Treatments, Testing and Advancements ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address GERM ETF News HeadlinesAmplia Therapeutics Advances Cancer Drug TrialOctober 30, 2024 | markets.businessinsider.comMpox Variant Sparks Global Concern As Europe, China Ramp Up ScreeningAugust 19, 2024 | benzinga.comMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new company could become the next to soar like Nvidia.August 9 at 2:00 AM | The Oxford Club (Ad)Amplify ETFs to Liquidate Three ETFsAugust 15, 2024 | finance.yahoo.comTHNR Amplify Weight Loss Drug & Treatment ETFAugust 1, 2024 | seekingalpha.comETFMG Treatments Testing and Advancements ETFFebruary 11, 2024 | thestreet.comSee More Headlines GERM ETF - Frequently Asked Questions How have GERM shares performed this year? Amplify Treatments, Testing and Advancements ETF's stock was trading at $19.1577 on January 1st, 2025. Since then, GERM stock has increased by 0.0% and is now trading at $19.1577. How do I buy shares of Amplify Treatments, Testing and Advancements ETF? Shares of GERM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Amplify Treatments, Testing and Advancements ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Amplify Treatments, Testing and Advancements ETF investors own include Moderna (MRNA), PayPal (PYPL), Global X Robotics & Artificial Intelligence ETF (BOTZ), Walt Disney (DIS), NVIDIA (NVDA), Tesla (TSLA) and AbbVie (ABBV). Fund Details IssuerAmplify Fund NameAmplify Treatments, Testing and Advancements ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:GERM Inception Date6/17/2020 Fund ManagerCharles Ragauss, Qiao Duan WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkPrime Treatments, Testing and Advancements Index CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings2 Fund Statistics Assets Under Management$9.67 million Average Daily Volume$0.00 Discount/Premium-0.18% Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorAmplify Investments LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerVirtu Financial Options OptionableN/A Short Interest100 shs Miscellaneous Outstanding Shares500,000Beta0.84 Creation Unit50,000 Creation Fee$300.00 Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Top 4 GERM HoldingsInvesco Government & Agency Portfolio 12/31/2031Holding Weight: 99.70%Cash & OtherHolding Weight: 0.30%AstraZeneca PLCHolding Weight: 0.00%Gurnet Point Capital LLCHolding Weight: 0.00%Full Holdings Details This page (NYSEARCA:GERM) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Treatments, Testing and Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Treatments, Testing and Advancements ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GERM Stock Alerts